New study checks drug levels in breast milk for nursing moms

NCT ID NCT06888193

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how much of the drug bimekizumab passes into breast milk. Researchers will collect milk samples from 20 breastfeeding mothers with conditions like psoriasis or arthritis over several weeks. The goal is to understand potential exposure for nursing infants, not to treat the disease.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIDRADENITIS SUPPURATIVA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Up0122 101

    RECRUITING

    Milwaukee, Wisconsin, 53226, United States

  • Up0122 102

    RECRUITING

    Durham, North Carolina, 27710, United States

  • Up0122 103

    RECRUITING

    South Miami, Florida, 33155, United States

  • Up0122 105

    RECRUITING

    Santa Monica, California, 90404, United States

  • Up0122 201

    RECRUITING

    Vancouver, Canada

  • Up0122 202

    RECRUITING

    Calgary, Canada

  • Up0122 301

    RECRUITING

    Freiburg im Breisgau, Germany

  • Up0122 303

    RECRUITING

    Herne, Germany

  • Up0122 501

    RECRUITING

    Barcelona, Spain

  • Up0122 502

    RECRUITING

    Barcelona, Spain

  • Up0122 601

    RECRUITING

    Sankt Gallen, Switzerland

  • Up0122 602

    RECRUITING

    Lausanne, Switzerland

Conditions

The condition(s) this trial relates to.

Axial Spondyloarthritis hidradenitis suppurativa psoriasis psoriatic arthritis spondyloarthropathy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.